EP2448933
Trans-4-[[(5S)-5-[[[3,5-bis(tríflúormetýl)fenýl]metýl](2-metýl-2H-tetrasól-5-ýl)amínó]-2,3,4,5-tetrahýdró-7,9-dímetýl-1H-1-bensasepín-1-ýl]metýl]-sýklóhexankarboxýlsýra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.6.2010EP published:
28.8.2013EP application number:
10728558.7
EP translation filed:
15.10.2013Grant published:
15.11.2013EPO information:
European Patent Register
Max expiry date:
27.6.2030Expiry date:
27.6.2016
Title:
TRANS-4-[[(5S)-5-[[[3,5-BIS(TRIFLUOROMETHYL)PHENYL]METHYL](2-METHYL-2H-TETRAZOL-5-YL)AMINO]-2,3,4,5-TETRAHYDRO-7,9-DIMETHYL-1H-1-BENZAZEPIN-1-YL]METHYL]-CYCLOHEXANECARBOXYLIC ACID
Timeline
Today
28.6.2010EP application
28.8.2013EP Publication
15.10.2013Translation submitted
15.11.2013Registration published
27.6.2016Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
CHEN, XinchaoAddress:
Indianapolis, Indiana, US
Name:
FRANK, Scott, AlanAddress:
Indianapolis, Indiana, US
Name:
REMICK, David, MichaelAddress:
Indianapolis, Indiana, US
Name:
PEDERSEN, Steven, WayneAddress:
Indianapolis, Indiana, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
221708 PDate:
30.6.2009Country:
US
Classification
Categories:
C07D 403/12, A61K 31/55, A61P 9/10
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 13.5.2014
Expires: 27.6.2015
Payer: Örn Þór, slf.
Number: 6
Paid: 12.5.2015
Expires: 27.6.2016
Payer: Örn Þór, slf.